OTC Firms Should Improve Monograph Compliance, Registration – CDER
This article was originally published in The Tan Sheet
Executive Summary
CDER recommends the OTC industry ensure product innovations comply with monographs or have FDA approval prior to marketing. Umbrella-branding and facility registration rank high for the drug center in 2013.